| scholarly article | Q13442814 |
| P50 | author | Brian L Egleston | Q64877076 |
| P2093 | author name string | Yu-Ning Wong | |
| Alexander Kutikov | |||
| Robert G Uzzo | |||
| P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
| Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis | Q30437879 | ||
| Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. | Q33411401 | ||
| Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome | Q34552515 | ||
| Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma | Q35009888 | ||
| The natural history of observed enhancing renal masses: meta-analysis and review of the world literature | Q36366074 | ||
| Adjuvant therapy for high-risk renal cell carcinoma patients | Q36713532 | ||
| Enhancing renal masses with zero net growth during active surveillance | Q36734245 | ||
| A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy | Q36846388 | ||
| Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. | Q37086667 | ||
| Delayed intervention of sporadic renal masses undergoing active surveillance | Q37089146 | ||
| Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. | Q37435457 | ||
| Preoperative nomogram predicting 12-year probability of metastatic renal cancer | Q37700441 | ||
| Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model | Q40693109 | ||
| A postoperative prognostic nomogram for renal cell carcinoma | Q43976699 | ||
| Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort | Q44130026 | ||
| An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score | Q44231764 | ||
| Using protein expressions to predict survival in clear cell renal carcinoma | Q46058434 | ||
| Improved prognostication of renal cell carcinoma using an integrated staging system | Q46077267 | ||
| Rising incidence of renal cell cancer in the United States | Q46854143 | ||
| Solid renal tumors: an analysis of pathological features related to tumor size | Q47436302 | ||
| A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. | Q52007634 | ||
| Mathematical model to predict individual survival for patients with renal cell carcinoma. | Q52045534 | ||
| Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. | Q52975859 | ||
| The autopsy as a measure of accuracy of the death certificate. | Q53426786 | ||
| Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. | Q53577432 | ||
| A competing-risks nomogram for sarcoma-specific death following local recurrence | Q57846514 | ||
| A Nomogram Predicting 10-Year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer | Q59649675 | ||
| Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension | Q73106996 | ||
| Incidental renal tumors: casting doubt on the efficacy of early intervention | Q73935680 | ||
| Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer | Q77336558 | ||
| Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score | Q79557109 | ||
| Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis | Q79919784 | ||
| Multi-institutional validation of a new renal cancer-specific survival nomogram | Q80117659 | ||
| Rising incidence of small renal masses: a need to reassess treatment effect | Q80294352 | ||
| Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index | Q80553127 | ||
| Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience | Q81662641 | ||
| Predicting life expectancy in men with clinically localized prostate cancer | Q82237253 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 311-317 | |
| P577 | publication date | 2009-11-23 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram | |
| P478 | volume | 28 |
| Q35984076 | A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures |
| Q60308293 | A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer |
| Q44380016 | A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma |
| Q38557322 | Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis |
| Q38681793 | Active Surveillance for Small Renal Masses: A Review of the Aims and Preliminary Results of the DISSRM Registry |
| Q38381367 | Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes |
| Q38057793 | Active surveillance for small renal tumors: have clinical concerns been addressed so far? |
| Q38097280 | Active surveillance of small renal masses |
| Q39698263 | Active surveillance: a potential strategy for select patients with small renal masses |
| Q38001225 | Approach to the small renal mass: to treat or not to treat |
| Q37679159 | Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status |
| Q58556304 | Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis |
| Q57565097 | Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses |
| Q55135907 | Clinical decision making in cancer care: a review of current and future roles of patient age. |
| Q33851709 | Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy |
| Q43539037 | Commentary on "Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenarians." Berger J, Fardoun T, Brassart E, Capon G, Bigot P, Bernhard JC, Rigaud J, Patard JJ, Descazeaud A, Department of Urology, Dupuytren Unive |
| Q47798767 | Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms |
| Q39244278 | Comparative Effectiveness of Surgical Treatments for Small Renal Masses |
| Q90484688 | Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery |
| Q44087258 | Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities |
| Q44255441 | Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? |
| Q91741812 | Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis |
| Q36319704 | Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model |
| Q39411540 | Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time |
| Q34062429 | Contemporary incidence and mortality rates of kidney cancer in the United States |
| Q58104098 | Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation |
| Q56761470 | Development and Validation of Nomograms for Predicting Overall and Breast Cancer-Specific Survival in Young Women with Breast Cancer: A Population-Based Study |
| Q97538060 | Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis |
| Q33728114 | Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection |
| Q90661565 | Diagnostic Accuracy of MRI for Detection of Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis |
| Q37274231 | Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? |
| Q95424269 | Editorial Comment |
| Q38739744 | Emerging surgical treatments for renal cell carcinoma |
| Q51049616 | Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy. |
| Q50905895 | Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. |
| Q44888718 | External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses |
| Q34577647 | Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions |
| Q47253613 | Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy |
| Q35569497 | Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance |
| Q52601583 | Image-guided minimally invasive treatment for small renal cell carcinoma. |
| Q42640706 | Impact of comorbidity on complications after nephrectomy: use of the Clavien Classification of Surgical Complications |
| Q34548164 | Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer |
| Q38246620 | Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery? |
| Q37838249 | Kidney cancer in 2010: drugs, surgery and survival in RCC. |
| Q51802639 | Kidney cancer: A new nomogram predicting survival in renal cell carcinoma. |
| Q38031647 | Laparoscopic cryoablation of renal masses: single-center long-term experience |
| Q44011209 | Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable |
| Q34902619 | Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma |
| Q36070403 | Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis. |
| Q38829480 | Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis |
| Q52837255 | National treatment trends among older patients with T1-localized renal cell carcinoma. |
| Q39691300 | Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. |
| Q94586061 | Nomograms to predict 2-year overall survival and advanced schistosomiasis-specific survival after discharge: a competing risk analysis |
| Q60302393 | Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma |
| Q47721185 | Online tools for patient counseling in bladder and kidney cancer-ready for prime time? |
| Q30626270 | Overall survival advantage with partial nephrectomy: a bias of observational data? |
| Q58798343 | Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis |
| Q49381468 | Pathological heterogeneity in sporadic synchronous renal tumors: Is the histological concordance predictable? |
| Q43247568 | Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings |
| Q26783525 | Percutaneous biopsy for risk stratification of renal masses |
| Q46590684 | Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours |
| Q41346920 | Population-based assessment of cancer-specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis |
| Q39244306 | Postoperative Surveillance for Renal Cell Carcinoma |
| Q35738214 | Predicting factors for death from other causes in patients with localized renal cell carcinoma |
| Q40458422 | Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer. |
| Q63966811 | Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study |
| Q37974504 | Predictive models for the practical management of renal cell carcinoma |
| Q34899343 | Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. |
| Q34813217 | Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors |
| Q92627474 | Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients with Major Salivary Gland Mucoepidermoid Carcinoma |
| Q91998697 | Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma |
| Q98210301 | Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database |
| Q34174451 | Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma |
| Q34029623 | Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis |
| Q36514165 | Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics |
| Q42687939 | Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation. |
| Q38682520 | Renal Cancer in the Elderly |
| Q50941188 | Renal cancer. |
| Q30234787 | Risk Assessment in Small Renal Masses: A Review Article. |
| Q53550200 | Small renal mass management in the elderly and the calibration of risk. |
| Q26738778 | Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies |
| Q35087063 | Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis |
| Q34757109 | Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma |
| Q44306533 | Surgery versus surveillance of small renal masses: a call for comparative effectiveness research in the management of kidney tumors |
| Q92625843 | Surgical treatment for renal masses in the elderly: analysis of oncological, surgical and functional outcomes |
| Q38891567 | Surveillance of Small Renal Masses |
| Q91739085 | Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis |
| Q38782652 | Systemic adjuvant therapy for renal cell carcinoma: Any hope for future clinical trials? |
| Q49203209 | The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma |
| Q52722675 | The effect of age on cancer specific mortality in patients with small renal masses: A population-based analysis. |
| Q45081445 | The effect of race and gender on the surgical management of the small renal mass |
| Q38757084 | The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols |
| Q63966724 | The natural history of large renal masses followed on observation |
| Q38005933 | The role of minimally invasive surgery in multifocal renal cell carcinoma |
| Q38202887 | Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death |
| Q98507555 | Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform |
| Q48118398 | Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy |
| Q36849038 | Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma |
| Q31141245 | Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data |
| Q36336664 | Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass |
| Q37281951 | Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. |
Search more.